Copyright © 2001 by the European Society of Cardiology.
Editorials
Endothelin: a new marker of risk of rapid coronary stenosis progression in patients with stable angina?
Cattedra di Cardiochirurgia, Università di Roma Tor Vergata, Rome, Italy
References
- Fuster V, Badimon L, Badimon JJ, Chesebro JH. Mechanisms of disease: the pathogenesis of coronary artery disease and the acute coronary syndromes (part one). N Engl J Med. 1992;326:242–250[ISI][Medline]
- Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart. 1999;82:265–268
[Abstract/Free Full Text] - Hickey KA, Rubanyl G, Paul RJ, Highsmith RF. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol. 1985;248:C550–555
- Yanagisawa M, Kurihara H, Kimura S. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411–415[CrossRef][Medline]
- Ferri C, Properzi G, Santucci A. Endothelin-1: a pathogenetic factor in human diseases or a physiologist's curiosity? High Blood Press. 1995;4:1–19
- Luscher TF, Barton M. Endothelins and endothelin receptor antagonists. Therapeutic considerations for a novel class of cardiovascular drugs. Circulation. 2000;102:2434–2440
[Abstract/Free Full Text] - Hasdai D, Holmes DR, Garrat KN, Edwards WD, Lermann A. Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. Circulation. 1997;95:357–362
[Abstract/Free Full Text] - Martin-Nizard F, Houssaini HS, Lestavel-Delattre S, Duriez P, Fruchart JC. Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin. FEBS Lett. 1991;293:127–130[CrossRef][ISI][Medline]
- Toyo-oka T, Aizawa T, Suzuki N. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation. 1991;83:476–483
[Abstract/Free Full Text] - Kaski JC, Elliott PM, Salomone O. Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J. 1995;74:620–624
[Abstract/Free Full Text] - Desideri GB, Gaspardone A, M. Gentile M, Santucci A, Gioffrè PA, Ferri C. Endothelial activation in patients with cardiac syndrome X. Circulation. 2000;102:2359–2364
[Abstract/Free Full Text] - Cardillo C, Kilcoyne CM, Cannon III, Panza JA. Increased activity of endogenous endothelin in patients with hypercholesterolemia. J Am Coll Cardiol. 2000;36:1483–1488
[Abstract/Free Full Text] - Zouridakis EG, Schwartzman R, Garcia-Moll X. Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. Eur Heart J. 2001;22:1578–1584
[Abstract/Free Full Text] - Zeiher AM, Goebel H, Schachinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation. 1995;91:941–947
[Abstract/Free Full Text] - Gaspardone A, Ferri C, Versaci F. Endothelin-1 and coronary vasoreactivity in unstable angina. Eur Heart J. 1999;20:654
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. L. McNair, D. A. Salamanca, and R. A. Khalil Endothelin-1 Promotes Ca2+ Antagonist-Insensitive Coronary Smooth Muscle Contraction Via Activation of {epsilon}-Protein Kinase C Hypertension, April 1, 2004; 43(4): 897 - 904. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||